This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Index investing focuses on steady, broad exposure to markets, helping you grow wealth over the long run with reduced complexity and lower costs.
27,799 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Lululemon faces renewed headwinds as leadership shifts and governance questions surface. This comprehensive look brea...
Verizon is shrinking its footprint and workforce as it pivots to a franchise-based retail model and tighter costs. Th...
Meme coins can surprise with sudden moves, and Pepe is no exception. This article unpacks the drivers behind a sharp ...
Canaccord Genuity lowers AeroVironment's target to $330 but preserves a Buy rating, underscoring long-term optimism a...
JPMorgan cuts McDonald’s price target to $305 amid softer same-store-sales, signaling a shift toward efficiency at ex...
Salesforce’s AI roadmap has captivated many, but the stock has faced a steep pullback. This article weighs the bulls’...
Investors sent Joby Aviation stock higher after the company topped expectations on its latest results. This article b...
Investor confidence is up—what’s making headlines? This article breaks down the forces behind a sunnier mood, what it...
Two tech powerhouses sit at the AI crossroads. This article breaks down the nvidia stock micron stock dynamic, what h...
State Farm is rolling out an AI-driven claims platform as part of a broader push to reinvent pricing and service. The...
A billionaire investor backed D-Wave Quantum in late 2024, and the stock has surged and slumped in a choppy 2026 trad...